Immuno-biology of Chikungunya and implications for disease intervention
Authors:
- Yiu-Wing KamYiu-Wing Kam
- Edward K.S. OngEOEdward K.S. Ong
- Laurent RéniaLRLaurent Rénia
- Joo-Chuan TongJTJoo-Chuan Tong
- Lisa F.P. NgLNLisa F.P. Ng
- 1 December 2009
- journal article
- review article
- Published by Elsevier in Microbes and Infection
- Vol. 11 (14-15) , 1186-1196
Abstract
No abstract availableKeywords
This publication has 95 references indexed in Scilit:
- Pan-specific MHC class I predictors: a benchmark of HLA class I pan-specific prediction methodsBioinformatics, 2008
- Chimeric alphavirus vaccine candidates for chikungunyaVaccine, 2008
- Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virusVaccine, 2008
- Antibodies against viruses: passive and active immunizationCurrent Opinion in Immunology, 2008
- Semliki Forest Virus Nonstructural Protein 2 Is Involved in Suppression of the Type I Interferon ResponseJournal of Virology, 2007
- The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disordersClinical and Experimental Immunology, 2007
- Capsid Protein of Eastern Equine Encephalitis Virus Inhibits Host Cell Gene ExpressionJournal of Virology, 2007
- A DNA Vaccine for Ebola Virus Is Safe and Immunogenic in a Phase I Clinical TrialClinical and Vaccine Immunology, 2006
- Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic feverNature Medicine, 2003
- An epidemic of virus disease in Southern Province, Tanganyika territory, in 1952–1953Transactions of the Royal Society of Tropical Medicine and Hygiene, 1955